The court’s injunction prevents generic manufactures to distribute generic Pulmicort Respules, until it reaches a final decision on AstraZeneca’s appeal of the verdict of the US District Court for the ...
Budesonide (micronized) 0.25mg/2mL, 0.5mg/2mL, 1mg/2mL; susp for inhalation. Pulmicort Respules is supplied in sealed aluminum foil envelopes containing one plastic strip of five single-dose Respules ...
On 20 May 2009, the US District Court for the District of New Jersey granted AstraZeneca's request for an injunction barring Apotex (Apotex, Inc. and Apotex Corp.) from launching a generic version of ...
Research and Markets: Investigation Report on China's Budesonide (Pulmicort Respules) Market to 2018
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/5rp48m/investigation) has announced the addition of the "Investigation ...
Recently, United States District Court for the District of New Jersey dealt a blow to AstraZeneca (AZN) when it ruled that a patent (6,598,603) protecting Pulmicort Respules (budesonide inhalation ...
On 19 November 2008, AstraZeneca was granted a Temporary Restraining Order (TRO) by the United States District Court for the District of New Jersey, halting sales of Teva's budesonide inhalation ...
AstraZeneca today announced that the United States District Court for the District of New Jersey ruled that AstraZeneca's US Patent No. 6,598,603 ("the '603 patent"), protecting PULMICORT RESPULES in ...
San Diego, Calif. – May 24, 2005 – Young children who are adherent with asthma controller therapies overall, and specifically PULMICORT RESPULES® (budesonide inhalation suspension), have lower ...
Sept. 28, 2005 ( updated Oct. 6, 2005) -- The U.S. Food and Drug Administration (FDA) approved safety labeling revisions in June to advise that doxercalciferol dose reductions are recommended in ...
A US court has confirmed that a key patent on AstraZeneca’s Pulmicort Repsules is invalid and Actavis has immediately launched its version of the asthma drug. A US court has confirmed that a key ...
A week is not normally a long time in patent disputes but it has been long enough for AstraZeneca and Teva to settle their difference over a generic version of the former’s asthma drug Pulmicort. A ...
Budesonide (micronized) 90mcg/inh, 180mcg/inh; dry pwd for inhalation. Pulmicort Flexhaler is available as a dry powder for inhalation containing budesonide in the following 2 strengths: 90 mcg and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results